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RESEARCH ARTICLE
Quality assessment in general practice: diagnosis and antibiotic treatment
of acute respiratory tract infections
Laura Trolle Sausta,b, Lars Bjerrumb, Volkert Siersmab, Magnus Arpia and Malene Plejdrup Hansenc,d
aDepartment of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark; bSection of General
Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark;
cResearch Unit for General Practice, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; dAudit Project Odense,
Department of Public Health, University of Southern Denmark, Odense, Denmark
ABSTRACT
Objective: To investigate areas in need of quality improvement within the diagnostic process
and antibiotic treatment of acute respiratory tract infections (RTIs) in Danish general practice by
using quality indicators (QIs).
Design and setting: During a 4-week period in winter 2017, a prospective registration of
patients diagnosed with RTIs was conducted in general practice in two regions of Denmark.
Subjects: Throughout the registration period each patient with symptoms of an RTI was regis-
tered. Information about age, symptoms and findings, duration of symptoms, the use and result
of clinical tests, allergy towards penicillin, referral to secondary care and the antibiotic given
were recorded.
Main outcome measures: Values and acceptable ranges for QIs focusing on the diagnostic pro-
cess, the decision to prescribe antibiotics and the choice of antibiotics for patients with RTIs.
Results: Regarding the diagnostic process nearly all QIs for patients diagnosed with acute phar-
yngotonsillitis and pneumonia fell within the acceptable range. Contrarily, the diagnostic QIs for
patients with acute otitis media and acute rhinosinusitis were outside the acceptable range. All
indicators designed to measure overuse of antibiotics were outside the acceptable range and
nearly all indicators assessing if patients were sufficiently treated fell within the acceptable
range. QIs assessing use of the recommended type of antibiotic were only within the acceptable
range for patients diagnosed with acute pharyngotonsillitis.
Conclusion: The findings indicate an overuse of antibiotics for RTIs in Danish general practice.
Especially management of acute rhinosinusitis and acute bronchitis should be targeted in future
quality improvement projects.
KEY POINTS:
 To improve antibiotic prescribing in general practice it is important to focus on both the
diagnostic process and the prescribing patterns.
 The findings indicate an overuse of antibiotics for acute respiratory tract infections in Danish
general practice.
 Especially the diagnostic process and antibiotic prescribing patterns for acute rhinosinusitis
and acute bronchitis could benefit from future quality improvement interventions.
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Introduction
Antimicrobial resistance (AMR) has reached alarming
levels in many parts of the world and is considered to
be one of the largest threats to global health [1].
Reducing the unnecessary use of antibiotics is essen-
tial when facing AMR [2,3]. General practice is respon-
sible for the majority of antibiotics prescribed to
humans [4]. Antibiotic prescriptions are often issued to
patients with acute respiratory tract infections (RTIs)
even though the effect is small, if any [5,6]. Despite
increasing awareness of AMR, antibiotic prescribing
remains high in general practice [4]. When fighting
the unnecessary use of antibiotics, insight into data
about antibiotic prescribing in combination with phys-
ician education has proven to be effective [7]. Often
information about the antibiotic prescribing patterns
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is provided as overall primary care antibiotic consump-
tion. Few European countries are able to link antibiotic
prescriptions to specific diagnoses [8,9]. Thus, a recent
Danish study was able to characterise antibiotic pre-
scribing patterns for RTIs in Danish general practice by
linking prescription data with specific clinical indica-
tions [10]. However, the available data may not cap-
ture a sufficiently detailed picture of antibiotic
prescribing. To improve the use of antibiotics it is
essential to include information about both the diag-
nostic process and the decision behind prescribing in
order to identify focus areas for future interventions.
Recently, quality indicators (QIs) for patients pre-
senting to general practice with symptoms of an RTI
have been developed [11]. This set of indicators com-
prises both the diagnostic process, the decision to pre-
scribe antibiotics and the type of antibiotic prescribed.
QIs are measurable elements that are proven to be a
significant stimulus in the improvement of antibiotic
prescribing [12]. By means of this set of newly devel-
oped QIs, we aimed to investigate areas in need of
quality improvement within the diagnostic process
and antibiotic treatment of RTIs in Danish gen-
eral practice.
Methods
Setting
This study is part of a larger quality improvement pro-
ject from Audit Project Odense (APO) [13] with the
overall aim of improving the management of patients
presenting to general practice with symptoms of an
RTI [14]. All general practices in the North Denmark
Region and the Region of Southern Denmark were
invited to participate in a prospective registration of
patients diagnosed with an RTI. Throughout a 4-week
registration period from January to February 2017
each patient consulting general practice with symp-
toms of an RTI was registered. The diagnosis of RTI
was based on the assessment and diagnostics of the
attending healthcare professional. Only patients who
consulted the clinic for the first time for the current
RTI were included.
Subjects and analyses
For each patient the following information was
recorded: age, symptoms and findings, the duration of
symptoms, the use and result of point-of-care tests
(rapid Streptococcus A antigen detection (Strep A) test
and C-reactive protein rapid (CRP) test), the use of
tympanometry or x-ray, and if the patient had any
known allergy towards penicillin. At the end of the
consultation the final diagnosis and management (þ/-
antibiotics, type of antibiotic or referral to secondary
care) were recorded.
In 2017 a set of 50 evidence-based QIs for the diag-
nosis and antibiotic treatment of RTIs were developed
by means of a RAND Appropriateness Method. Each
indicator was developed with a standard (acceptable
range) that embodied acceptability of the particular
performance addressed by that indicator [11]. Of these
50, 39 QIs were applicable to the data collected in the
current study. Consequently, we calculated values (in
percentage) for 39 QIs and compared these values
with the acceptable ranges. 95% confidence intervals
were calculated by transforming back to proportions
the Normal approximation interval for the odds, so as
to avoid intervals stretching below 0% or over 100%.
Data were analysed using SAS 9.4.
Results
A total of 44 (8.5%) of the invited practices partici-
pated in the study. During the registration period the
participating 256 healthcare professionals registered
6124 consultations of patients presenting to general
practice with symptoms of an RTI. Of these, 2323
patients were diagnosed with either acute pharyngo-
tonsillitis, acute otitis media, acute rhinosinusitis, acute
bronchitis, pneumonia or acute exacerbation of COPD,
according to the second edition of International
Classification of Primary Care (ICPC-2) [15]. The remain-
ing patients with symptoms of an RTI were mainly
diagnosed with common cold.
Table 1 shows the value and acceptable range for
QIs focusing on the diagnostic process. Five out of the
nine QIs were within the acceptable range. Nearly
90% of patients with acute pharyngotonsillitis fulfilling
2-3 modified Centor criteria (Temperature 38 C, ton-
sillar coating, tender cervical lymphadenitis, absence
of cough, patient age (þ 1 point for age 3–14 years,
-1 point for age less than 3 years, -1 point for age 45
years and above)) were examined with a strep A test.
However, more than 70% of patients fulfilling 0-1
modified Centor criteria were also examined with a
strep A test despite that Danish guidelines recom-
mend not to test these patients. All four diagnostic
QIs for patients with pneumonia fell within the accept-
able range.
Table 2 demonstrates the value and acceptable
range for QIs focusing on the decision to prescribe
antibiotics. Ten QIs were primarily designed to assess
overuse of antibiotics (a low value is associated with a
high quality of antibiotic prescribing). None of these
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indicators were within the acceptable range. For
example, more than 60% of patients diagnosed with
acute rhinosinusitis were prescribed an antibiotic and
37% of patients diagnosed with acute pharyngotonsil-
litis and fulfilling 0-1 modified Centor criteria were
prescribed antibiotics, despite no antibiotic indication
according to the Danish guidelines. Use of antibiotics
for patients diagnosed with acute bronchitis also
exceeded the 10% upper limit of acceptable use.
Another six QIs focusing on the decision to pre-
scribe antibiotics were primarily designed to assess if
patients were treated with antibiotic when it is recom-
mended (a high value is associated with a high quality
of antibiotic prescribing). Four of these QIs were
within the acceptable range and the remaining two
fell very close to the acceptable range.
Value and acceptable range for QIs focusing on the
choice of antibiotics are shown in Table 3. Two out of
the 14 QIs were within the acceptable range. The pro-
portion of patients treated with penicillin V (first-line
antibiotic for most RTIs in Denmark) was calculated for
five diagnoses, but was only within the acceptable
range for patients diagnosed with acute pharyngoton-
sillitis. Prescribing penicillin V to patients with acute
bronchitis and AOM deviated the most from the
acceptable range by 34 and 30% respectively. A total
of 19% of AOM patients treated with antibiotics were
prescribed amoxicillin þ/- clavulanic acid (within the
acceptable range). We found that more than 75% of
patients diagnosed with any of the RTIs and treated
with macrolides had no known allergy to penicillin.
Discussion
Main findings
According to the diagnostic process nearly all QIs for
patients with acute pharyngotonsillitis and pneumonia
fell within the acceptable range. Contrary, the diag-
nostic QIs for patients with AOM and acute rhinosinu-
sitis were outside the acceptable range. All indicators
designed to measure overuse of antibiotics were also
outside the acceptable range, while nearly all indica-
tors assessing if patients were sufficiently treated with
antibiotics fell within the acceptable range. QIs assess-
ing the use of first-line antibiotic were only within the
acceptable range for patients with acute pharyngoton-
sillitis (95% treated with penicillin V). Finally, we found
that most of the patients treated with macrolides had
no known allergy to penicillin.
Strengths and limitations
To our knowledge, this is the first study to investigate
general practice management of patients with RTIs;
comprising both the diagnostic process; the decision
to prescribe and the type of antibiotic prescribed by
Table 1. Values and acceptable ranges for 9 quality indicators focusing on the diagnostic process in Danish general prac-
tice (2017).
Quality indicatorsa
Patientsa
(n : n)
Value (95%CI)
(%)
Acceptable range
(%)
Patients with acute pharyngotonsillitis (N¼ 501)
Patients fulfilling 2–3 modified Centor criteriab examined with a Strep A
test : patients fulfilling 2–3 modified Centor criteriab
214 : 241 88.8 (84.4–92.4) 80–100
Patients fulfilling 0–1 modified Centor criteriab examined with a Strep A
test : patients fulfilling 0–1 modified Centor criteriab
83 : 115 72.2 (63.6–79.8) 0–10
Patients with acute otitis media (N¼ 347)
Patients >6 monthsc with an evaluation of the eardrum mobilityd:
patients >6 monthsc
162 : 342 47.4 (42.1–52.7) 70–100
Patients with acute rhinosinusitis (N¼ 330)
Patients with >10 days symptom duration or increasing symptoms after
5 days : patients
139 : 330 42.1 (36.9–47.5) 90–100
Patients with pneumonia (N¼ 530)
Patients fulfilling <2 diagnostic criteriae: patients 39 : 530 7.4 (5.3–9.8) 0–20
Patients examined with a CRP test: patients 434 : 530 81.9 (78.5–85) 80–100
Patients with a CRP test <20mg/l : patients 50 : 530 9.4 (7.1–12.1) 0–20
Patients examined with an X-ray of thorax : patients 38 : 530 7.2 (5.2–9.6) 0–30
Patients with acute exacerbation of chronic obstructive pulmonary dis-
ease (N¼ 147)
Patients with acute exacerbation of dyspnea, coughing and/or expector-
ation greater than the daily variation : patients
113 : 147 76.9 (69.6–83.2) 90–100
Within the acceptable range.
aPresented as numerator: denominator.
bTemperature 38 C, tonsillar coating, tender cervical lymphadenitis, absence of cough, patient age (þ1 point for age 3–14 years, -1 point for age less
than 3 years, -1 point for age 45 years and above).
cValues are calculated for patients aged 1 year.
dEvaluated by tympanometry or pneumatic otoscopy.
eSymptoms of lower respiratory tract infection (cough þ/ expectoration), emerging findings on examination of the chest (tachypnea, damping and/or
auscultation of murmurs), signs of systemic disease (systemically unwell and/or temperature >38 C).
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means of QIs. Anyhow, this study also has some
limitations.
The QIs used in this study were originally designed
to describe the quality of GPs management of patients
with RTIs. However, in Danish general practice many
patients with RTIs are consulted by other healthcare
professionals, often nurses [14]. Consequently, we
wanted to investigate the quality of diagnosis and
antibiotic treatment of acute RTIs in general practice,
regardless of the type of healthcare professional con-
sulting the patients. As the same guidelines apply to
all healthcare professionals working in general
practice, we argue that it is acceptable to apply these
indicators to data collected during an APO audit
involving both GPs and other healthcare professions.
The healthcare professionals volunteering in this
study may have been more interested in the topic
being investigated and may be more likely to follow
guidelines than non-participating healthcare professio-
nals [16]. Consequently, the study participants are
probably not representative of the average Danish
healthcare professionals working in general practice,
which could lead to an underestimation of the
inappropriateness of antibiotic prescribing. Taking this
Table 2. Values and acceptable ranges for 16 quality indicators focusing on the decision to prescribe antibiotics in Danish
general practice (2017).
Quality indicatorsa
Patientsa
(n : n)
Value (95%CI)
(%) Acceptable range (%)
Patients with acute pharyngotonsillitis (N¼ 501)
Patients with a positive Strep A test treated with antibiotics: patients with a
positive Strep A test
247 : 248 99.6 (98.2–100) 90–100
Patients fulfilling 0–1 modified Centor criteriab treated with antibiotics:
patients fulfilling 0–1 modified Centor criteriab,c
42 : 115 36.5 (28.1–45.5) 0–10
Generally affected patients fulfilling 4–5 modified Centor criteriab treated
with antibiotics : generally affected patients fulfilling 4–5 modified
Centor criteriab
30 : 31 96.8 (86.6–99.8) 90–100
Patients with acute otitis media (N¼ 347)
Patients <6 monthsd treated with antibiotics: patients <6 monthsd 3 : 4 75 (27.8–98.4) 90–100
Patients >6 monthse with no signs of fluid in the middle ear6 treated with
antibiotics: patients >6 monthse with no signs of fluid in the middle eare,c
1 : 3 33.3 (2.3–83.9) 0–10
Patients >6 monthse with 3 days of acute ear pain and no signs of fluid in
the middle earf treated with antibiotics : patients >6 monthse with 3 days
of acute ear pain and no signs of fluid in the middle earf,c
0 : 0 – 0–10
Patients with acute rhinosinusitis (N¼ 330)
Patients treated with antibiotics : patientsc 213 : 330 64.5 (59.3–69.6) 5–10
Patients with a CRP test <10mg/l treated with antibiotics: patients with a
CRP test <10mg/l3
34 : 87 39.1 (29.3–49.5) 0–10
Patients fulfilling <3 diagnostic criteriag treated with antibiotics: patients ful-
filling <3 diagnostic criteriag,c
108 : 197 54.8 (47.8–61.7) 0–10
Patients fulfilling >3 diagnostic criteriag treated with antibiotics: patients ful-
filling >3 diagnostic criteriag
105 : 133 78.9 (71.5–85.3) 80–100
Patients with <5 days symptom duration treated with antibiotics: patients
with <5 days symptom durationc
47 : 80 58.8 (47.8–69.1) 0–10
Patients with acute bronchitis (N¼ 468)
Patients treated with antibiotics: patientsc 106 : 468 22.6 (19–26.6) 0–10
Patients with purulent expectorate treated with antibiotics: patients with
purulent expectoratec
42 : 100 42 (32.6–51.8) 0–10
Patients with pneumonia (N¼ 530)
Patients treated with antibiotics : patients 498 : 530 94 (91.7–95.8) 90–100
Patients <65 year fulfilling <2 diagnostic criteriah treated with antibiotics:
patients <65 year fulfilling <2 diagnostic criteriah,c
24 : 26 92.3 (78.1–98.7) 0–20
Patients with acute exacerbation of chronic obstructive pulmonary dis-
ease (N¼ 147)
Patients fulfilling 2–3 Anthonisen criteriai treated with antibiotics : patients
fulfilling 2–3 Anthonisen criteriai
78 : 82 95.1 (89–98.5) 90–100
Within the acceptable range.
aPresented as numerator: denominator;
bTemperature 38 C, tonsillar coating, tender cervical lymphadenitis, absence of cough, patient age (þ 1 point for age 3–14 years, -1 point for age less
than 3 years, -1 point for age 45 years and above).
cQuality indicator primarily designed to measure overuse of antibiotics.
dValues are calculated for children aged <1 year.
eValues are calculated for patients aged 1 year
fEvaluated by tympanometry or pneumatic otoscopy and the absence of ear discharge.
gDiscolored nasal discharge and/or purulent secretion in the nasal cavities, strong localised pain, fever (>38 C), elevated CRP, exacerbation after remis-
sion of the disease.
hSymptoms of lower respiratory tract infection (cough þ/- expectorate), emerging findings on examination of the chest (tachypnea, damping and/or aus-
cultation of murmurs), signs of systemic disease (systemically unwell and/or temperature >38 C).
iIncreased dyspnea, increased expectorate, increased purulence of expectorate. If only two criteria are met, one of them has increased purulence of
expectorate.
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into account the amount of inappropriate antibiotic
prescribing exposed in this study may be even more
extensive in general.
Ambivalent information on antibiotic prescribing
was given in 27 (out of 2323) cases; we choose to
view these as if antibiotics were not prescribed. This
information bias could lead to the value of the QIs
deviating further from the acceptable ranges.
However, since the QIs designed to assess overuse of
antibiotics all deviated from the acceptable ranges it
is unlikely to bias our conclusions.
Comparison with other studies
Quality indicators focusing on the diagnos-
tic process
Nearly 90% of patients with acute pharyngotonsillitis
fulfilling 2-3 modified Centor criteria were examined
with a strepA test, indicating that strepA test is used
in the case of moderate risk of infection with group A
beta-hemolytic streptococci (GABHS) as recommended
in Danish guidelines [17]. These guidelines also stress
that the StrepA test should not be used when the risk
of GABHS is very low (0-1 modified Centor criteria
fulfilled). The fact that more than 70% of the patients
fulfilling only 0-1 modified Centor criteria also were
examined with a strepA test implies that strepA tests
are used extensively, and not always in accordance
with the Danish guidelines [17]. When patients with
symptoms of a viral infection are examined with a
strepA test there is a risk of a positive test (due to
detection of commensal strains), and this group of
patients will not likely benefit from antibiotic treat-
ment [18]. As a positive strepA test often results in an
antibiotic prescription it ultimately leads to antibiotic
overuse. In Sweden, extensive use of strepA tests has
also been observed and its possible influence on anti-
biotic overuse is being investigated [19].
More than 50% of all patients (aged> one year)
diagnosed with AOM never had an evaluation of their
eardrum mobility. Studies have shown that tympan-
ometry or pneumatic otoscopy can improve the diag-
nostic quality of AOM [20]. However, Danish
guidelines on management of children with AOM are
conflicting. One guideline recommends that tympan-
ometry or pneumatic otoscopy must be used as part
of the diagnosis of AOM [21]. Contrary, another guide-
line states that GPs can consider using tympanometry
or pneumatic otoscopy as part of the diagnosis [17]. It
is possible that our results reflect the conflicting
recommendations.
According to European Position Paper on
Rhinosinusitis and Nasal Polyps [22] acute rhinosinusi-
tis is subdivided into common cold, in which the dur-
ation of symptoms is less than ten days, and acute
post-viral rhinosinusitis defined by deterioration of
symptoms after five days or persistence beyond ten
days. We found that nearly 60% of the patients diag-
nosed with acute rhinosinusitis have had symptoms
for less than ten days nor any deterioration of symp-
toms, indicating that a significant amount of these
Table 3. Values and acceptable ranges for 14 quality indicators focusing on the choice of antibiotics in Danish general prac-
tice (2017).
Quality indicatorsa
Patientsa
(n : n)
Value (95%CI)
(%)
Acceptable range
(%)
Patients with acute pharyngotonsillitis (N¼ 501)
Patients treated with penicillin V: patients treated with antibiotics 326 : 345 94.5 (91.8–96.6) 90–100
Patients without known penicillin allergy treated with macrolides: patients treated with macrolides 4 : 10 40 (14.6–70) 0–10
Patients with acute otitis media (N¼ 347)
Patients treated with penicillin V: patients treated with antibiotics 155 : 260 59.6 (53.6–65.5) 90–100
Patients treated with amoxicillin þ/- clavulanic acid: patients treated with antibiotics 50: 260 19.2 (14.8–24.3) 0–20
Patients without known penicillin allergy treated with macrolides: patients treated with macrolides 5 : 6 83.3 (44.6–99) 0–10
Patients with acute rhinosinusitis (N¼ 330)
Patients treated with penicillin V: patients treated with antibiotics 165 : 213 77.5 (71.5–82.7) 90–100
Patients without known penicillin allergy treated with macrolides: patients treated with macrolides 9 : 18 50 (28.1–71.9) 0–10
Patients with acute bronchitis (N¼ 468)
Patients treated with penicillin V: patients treated with antibiotics 59 : 106 55.7 (46.2–65) 90–100
Patients treated with amoxicillin þ/- clavulanic acid : patients treated with antibiotics 24 : 106 22.6 (15.4–31.2) 0–10
Patients without known penicillin allergy treated with macrolides: patients treated with macrolides 17 : 22 77.3 (57.4–91.2) 0–10
Patients with pneumonia (N¼ 530)
Patients treated with penicillin V: patients treated with antibiotics 313: 498 62.9 (58.5–67) 80–100
Patients without known penicillin allergy treated with macrolides : patients treated with macrolides 74 : 88 84.1 (75.5-90.7) 0–10†
Patients with acute exacerbation of chronic obstructive pulmonary disease (N¼ 147)
Patients without known penicillin allergy treated with quinolones: patients treated with quinolones 3 : 5 60 (19.9–91.9) 0–10
Patients with acute respiratory tract infection (N¼ 2323)
Patients without known penicillin allergy treated with macrolides: patients treated with macrolides 113 : 150 75.3 (68–81.8) 0–10
Within the acceptable range.
aPresented as numerator: denominator.
†This standard cannot be used during a mycoplasma epidemic.
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patients were more likely to have been diagnosed
with a common cold. These findings are in line with
previous literature demonstrating that the diagnosis
acute rhinosinusitis is used too often in general prac-
tice [23].
One has to keep in mind that the accurate diagno-
sis of pneumonia in general practice is challenging.
Consequently there is a hypothesis of diagnostic label-
ing (misclassification) between acute bronchitis and
pneumonia; that the physician tends to justify a pre-
scription for acute bronchitis by labeling it pneumonia
[24]. However, our findings contradict this hypothesis
by indicating a high diagnostic quality of pneumonia.
Few patients fulfilled less than two diagnostic criteria
(symptoms of lower respiratory tract infection (cough
þ/- expectoration), emerging findings on examination
of the chest (tachypnea, damping and/or auscultation
of murmurs), signs of systemic disease (systemically
unwell and/or temperature >38 C)) and had a CRP
test <20mg/l (Table 1). Furthermore, another study by
Van Vugt et al found that a combination of physical
examination with a CRP value improved the prediction
of radiographic verified pneumonia [25].
Quality indicators focusing on the decision to
prescribe antibiotics
All six QIs designed to assess if patients were suffi-
ciently treated with antibiotics were very close to or
within the acceptable range. In contrast, none of the
QIs designed to assess overuse of antibiotics reached
the acceptable range.
Nearly all patients with a positive strepA test were
treated with antibiotics. Similarly, patients with a high
risk of GABHS (patients fulfilling 4-5 modified Centor
criteria) were sufficiently treated with antibiotics.
However, 37% of patients with no indication for anti-
biotic treatment (patients fulfilling 0-1 modified
Centor criteria) were also treated. Importantly, it has
previously been demonstrated that Swedish GPs do
not recall the Centor criteria [26] and our findings indi-
cate that this might also be the issue in Danish gen-
eral practice.
We found that 23% of patients diagnosed with
acute bronchitis were treated with antibiotics. This is
the lowest prescribing percentage of the six diagnoses
studied. However, keeping in mind the lack of evi-
dence to support the use of antibiotics for acute bron-
chitis [27] this is a rather high prescribing percentage.
A very small proportion (0.5-2%) of patients with
acute rhinosinusitis develop acute bacterial rhinosinu-
sitis (ABRS) and only when 3 specific diagnostic crite-
ria are present the risk of ABRS is high [22]. We found
that more than half of the patients fulfilling <3 of
these criteria were treated with antibiotics. Our find-
ings suggest that antibiotic prescribing in patients
with acute rhinosinusitis is often not in agreement
with guidelines and a considerable amount of these
patients are probably exposed to overprescribing.
Other European studies have shown similar
results [28].
Quality indicators focusing on the choice of
antibiotics
A decrease in penicillin V and an increase in amoxicil-
lin are reported in the Danish Integrated Antimicrobial
Resistance Monitoring and Research Program
(DANMAP) report 2016 [29]. Importantly, the authors
of the DANMAP report claim that if these trends are
to continue amoxicillin will be the most commonly
used antibiotic in Denmark within the next few years.
We found that the use of penicillin V was within the
acceptable range only for patients diagnosed with
acute pharyngotonsillitis (95%) and deviated the most
for patients with acute bronchitis and AOM. These
findings are in line with a recent Danish registry-based
study demonstrating a high use of penicillin V for
acute pharyngotonsillitis (86%) and the lowest penicil-
lin V use for acute bronchitis [10]. The relatively low
use of penicillin V is not in accordance with Danish
guidelines recommendations indicating that current
choice of antibiotics could still be improved.
In Denmark, macrolide treatment is recommended
only when patients have allergy to penicillin or in case
of penicillin-resistant bacteria, sensible to macrolides,
detected by microbiological testing. We found that
more than 75% of the patients with acute RTIs treated
with macrolides had no known penicillin allergy. It
does not seem plausible to ascribe all of these 75% to
cases of penicillin-resistant bacteria, indicating an
overuse of macrolides. Of note, a Mycoplasma pneu-
moniae epidemic was observed in Denmark during
winter 2016–2017, which may account for some of
these prescriptions.
Antibiotic overprescribing in general practice
A Dutch study analysing GPs accordance with guide-
lines for patients with AOM, demonstrated both
under- and overprescribing of antibiotics [30].In this
study we found hardly any underprescribing and
mainly overprescribing of antibiotics for RTIs. For
example, many patients were prescribed antibiotics
despite fulfilling only one criterion (diagnostic criteria
or modified Centor criteria); although two or three
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criteria are required according to guidelines. It has
previously been demonstrated that criteria for anti-
biotic treatment stated in guidelines are recognised
by GPs as important items but not applied in a correct
manner [30]. It may be difficult for the GPs to under-
stand the value of combinations of multiple signs
and symptoms.
Multiple possible reasons for overprescribing exists,
one often mentioned is that clinicians feel pressured to
prescribe antibiotics because of patients’ expectations
[31]. The pressure to prescribe antibiotics can be real or
perceived as a result of the clinician’s perception
[31,32]. It has also been reported that clinicians tend to
take a ‘just in case’ approach, meaning that they rather
prescribe than not prescribe when they are uncertain
about the prescribing decision [32]. Furthermore, stud-
ies have shown that many clinicians do not believe
that antibiotic prescribing in primary care is responsible
for the increasing problems with antibiotic resistance
[33] and consequently not necessarily comply with new
recommendations and national action plans.
Perspectives
The findings of the study indicate an antibiotic over-
use for patients presenting to Danish general practice
with symptoms of an RTI. The QIs applied in this study
represent a useful tool to evaluate and compare the
quality of diagnosis and antibiotic treatment of RTIs in
general practice. These QIs could provide national dir-
ection for improvement strategies such as public cam-
paigns, physician education or organisational changes
in healthcare. The Danish national action plan for anti-
biotics to humans issued in 2017 [34] identifies two
main goals; to increase the proportion of penicillin V
of the total antibiotic consumption and to reduce the
number of redeemed prescriptions in general practice.
Structural changes to an already existing data capture
module for antibiotic prescriptions (Ordiprax) has been
proposed as an initiative to reach the goals from the
National action plan [34]. A systematic implementation
of the QIs used in the current study into this module
could meet the proposed initiatives. Furthermore, such
implementation could become beneficial for future
patients by assisting individual clinics striving to
improve care as well as to monitor national surveil-
lance targets on antibiotic use.
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